|
|
Article: Levitra Awareness and Interest Expand Erectile Dysfunction (ED) Market; Positive Influence of Levitra on Bayer Healthcare's Pharmaceuticals Business.
- Article from:
- PR Newswire
- Article date:
- April 29, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WEST HAVEN, Conn., April 29 /PRNewswire/ -- Last week, Bayer received regulatory approval of Levitra in Japan, making it the 83rd country in which Levitra has been approved. "The speed and breadth of Levitra launches throughout the world and the excellent global brand management are prime examples of Bayer Pharma's focus on driving growth of our key brands," said Dr. Wolfgang Plischke, Head of Bayer HealthCare AG Pharmaceutical Division. In addition, regulatory authorities in Canada approved Levitra in March.
Since the global launch of Levitra in 2003, sales have reached euro 200 million. First quarter worldwide Bayer sales of Levitra have reached euro 66 ...